Artal Group’s Regenxbio RGNX Stock Holding History

Artal Group’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-250,000	Closed	-$2.92M	–	77
2024 Q2	$2.92M	Hold	250,000	–	–	0.07%	69
2024 Q1	$5.27M	Buy	+250,000	New	+$4.45M	0.13%	62
2020 Q4	–	Sell	-222,300	Closed	-$6.12M	–	151
2020 Q3	$6.12M	Sell	222,300 -11,700	-5%	-$381K	0.15%	91
2020 Q2	$8.62M	Sell	234,000 -16,000	-6%	-$596K	0.24%	76
2020 Q1	$8.1M	Buy	250,000 +105,000	+72%	+$4.37M	0.34%	56
2019 Q4	$5.94M	Hold	145,000	–	–	0.23%	66
2019 Q3	$5.16M	Hold	145,000	–	–	0.21%	71
2019 Q2	$7.45M	Sell	145,000 -25,000	-15%	-$1.25M	0.3%	66
2019 Q1	$9.74M	Hold	170,000	–	–	0.4%	52
2018 Q4	$7.13M	Buy	170,000 +20,000	+13%	+$1.17M	0.26%	56
2018 Q3	$11.3M	Hold	150,000	–	–	0.29%	49
2018 Q2	$10.8M	Sell	150,000 -100,000	-40%	-$4.78M	0.23%	45
2018 Q1	$7.46M	Hold	250,000	–	–	0.09%	58
2017 Q4	$8.31M	Buy	250,000 +90,000	+56%	+$2.71M	0.13%	49
2017 Q3	$5.27M	Hold	160,000	–	–	0.09%	62
2017 Q2	$3.16M	Hold	160,000	–	–	0.06%	80
2017 Q1	$3.09M	Hold	160,000	–	–	0.07%	75
2016 Q4	$2.97M	Sell	160,000 -140,000	-47%	-$2.68M	0.07%	70
2016 Q3	$4.2M	Buy	300,000 +100,000	+50%	+$1.1M	0.08%	64
2016 Q2	$1.6M	Buy	200,000 +40,000	+25%	+$444K	0.03%	64
2016 Q1	$1.73M	Hold	160,000	–	–	0.03%	56
2015 Q4	$2.66M	Buy	160,000 +42,600	+36%	+$846K	0.05%	71
2015 Q3	$2.59M	Buy	+117,400	New	+$3M	0.06%	64

Other funds holding RGNX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

IHAM

Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Artal Group's RGNX Position: Q3 2024 in Review

Artal Group sold out of Regenxbio (RGNX) in Q3 2024, closing a stake of 250,000 shares — an estimated $2.92M sold.

Artal Group first reported a position in RGNX in Q3 2015 and held it in 23 quarters. The position peaked at $11.3M in Q3 2018. 186 funds tracked by Wall St. Rank hold RGNX as of Q3 2024.

Artal Group reported no remaining Regenxbio position as of Q3 2024 after selling out during the quarter.
Artal Group sold 250,000 Regenxbio shares in Q3 2024, an estimated $2.92M.
Artal Group first reported a position in Regenxbio in Q3 2015 and held it in 23 quarters.
Artal Group's Regenxbio position peaked at $11.3M in Q3 2018.
186 funds tracked by Wall St. Rank held Regenxbio as of Q3 2024.

Based on Artal Group's 13F filing for Q3 2024, filed 13 Nov 2024.